Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04327999 · ClinicalTrials.gov registry record · Phase 2
Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System
A Phase 2 study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT04327999 is a Phase 2 study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 9 participants.
The verdict
NCT04327999, a Phase 2 study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to explore whether administration of preservative free artificial tears will decrease the level of detectable radioiodine in the tears and nasolacrimal duct system of patients undergoing radioiodine therapy for thyroid carcinoma and thus decrease the risk of developing radioactive iodine associated nasolacrimal duct obstruction.
Interventions
- DRUG Artificial Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2023-09-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04327999
The ClinicalTrials.gov registry entry for NCT04327999 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artificial Tears is the first listed.
NCT04327999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04327999 about?
NCT04327999 is a clinical study titled "Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System". The purpose of this study is to explore whether administration of preservative free artificial tears will decrease the level of detectable radioiodine in the tears and nasolacrimal duct system of patients undergoing radioiodine therapy for thyroid carcinoma and thus decrease the risk of developing r...
What is the current status of trial NCT04327999?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2020-10-05. Estimated completion is 2023-09-25.
What interventions are being tested in trial NCT04327999?
The interventions under investigation include: Artificial Tears (DRUG).
Who is sponsoring clinical trial NCT04327999?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.